El GT3 relacionado con el objetivo específico 3 convergerá hacia la experimentación de acciones piloto en las áreas del proyecto. Estas acciones permitirán la implementación concreta de nuevos dispositivos (como servicios, equipos, herramientas, métodos o enfoques) derivados de una reflexión conjunta o demostrarán la viabilidad/transferibilidad de soluciones existentes a un territorio/sector específico.
Pilot test of the AI-based predictive platform “Henko” and innovative digital technologies with end-users of palliative care (A3.2): people with palliative care needs (N=120), family members (N=50), professionals (N=25). (1 pilot action implemented in the 7 care beneficiaries, INTRAS, GSS, HEALTH, DIPBI, CHUB, PM, IPO).
Prueba piloto de la plataforma predictiva “HENKO” basada en IA y tecnologías digitales innovadoras con usuarios finales de cuidados paliativos (A3.2): personas con necesidades de cuidados paliativos (N=120), familiares (N=50), profesionales (N=25). (1 acción piloto implementada en los 7 beneficiarios asistenciales, INTRAS, GSS, SALUD, DIPBI, CHUB, PM, IPO).
Pilot or mini-pilots of the “Tool Box” (A3.3): Brief experimentation of innovative technologies or services in the market or with sufficient technological maturity, as well as process innovations or care models. “Soft evaluation” methodology. (1 pilot action implemented in the 7 care beneficiaries, INTRAS, GSS, HEALTH, DIPBI, CHUB, PM, IPO).
Prueba piloto o mini-pilotos de la “Caja de Herramientas” (A3.3): Breve experimentación de tecnologías o servicios innovadores en el mercado o con suficiente madurez tecnológica, así como innovaciones de proceso o modelos de atención. Metodología “soft evaluation”. (1 acción piloto implementada en los 7 beneficiarios asistenciales, INTRAS, GSS, SALUD, DIPBI, CHUB, PM, IPO).
Conduct of a randomised multicenter clinical trial with intervention and control group in 300 elderly patients of the Geriatric/Internal Medicine service in the hospitals participating in the project. The hospital care model of the HUN Geriatrics Service has demonstrated, through scientific evidence, the prevention of disability generated during hospitalisation in 60 % of patients who perform the individualised exercise program. Starting from the basis of this model, and seeking its optimisation, an innovative hospital care model will be developed jointly that will be implemented in HDFF (Portugal), CHU-T (France), SAAS (Andorra) and HUN (Spain). The design of the clinical trial will take into account the needs, possibilities and characteristics of each hospital for its implementation and subsequent follow-up after 3 months of the intervention, in order to assess the adherence and the results of the practice of physical exercise and adoption of healthy habits. This pilot activity will begin with the joint elaboration of the protocol, and, after its approval by the different Ethical Committees, the recruitment of patients in the 3 hospitals that will be randomised through a blind procedure (month 7) will begin. The duration of the clinical trial is estimated at 2 years, and once completed, the results analysis will be carried out. The results of this pilot activity tested in the three hospitals will allow the development of a solution that can be easily transferred to other hospitals in different territories. The implementation of this pilot activity in three hospitals in different countries and regions brings added value to the results, since it includes a heterogeneous population with different social and economic characteristics of the SUDOE territory and with different health systems, increasing the impact of the results at a scientific level with social and political impact.
Implantación de 3 demostradores de robots colaborativos en un entorno productivo real centrados en 3 sectores diferentes de alta representatividad e impacto económico en el espacio SUDOE (cárnico, frutícola y plásticos) y 3 living labs para la integración y demostración de los resultados alcanzados en el marco del proyecto al tejido empresarial y otras entidades interesadas en implantar las soluciones desarrolladas, o equivalentes, en sus procesos productivos.
After the deployment and commissioning of the monitoring and control system, the locations/balconies will become the pilots of the project, where the data captured by the thermal water quality control system will be collected and analysed. These pilots will allow to evaluate the effectiveness of the system in real time and its ability to guarantee water quality in various thermal environments. The results obtained from these pilots will provide nexcessary information for the future implementation of the system in other spas within the Interreg SUDOE territory. Institute of Thermalism of the University of Bordeaux, a pilot in Portugal associated with the thermal pool of associate Gestão de Equipamentos do Município de Chaves, E.M., S.A., a pilot in the pool of the Hervideros de Cofrentes spa, a Pilot will unfold in the thermal pool of the Balneario El Raposo, a pilot will be developed by the associate Caldaria Termal SLU in the Spa of Laias and two pilots in resorts of France to define by HERE O Thermes, thermal cluster Nouvelle-Aquitaine, adding a total of 6 pilots
Este despliegue inicial sirve como base de trabajo para testar los diferentes procesos de adquisociòn de datos, capacidad del modelo, simulación de procesos contaminantes, etc. Una vez finalizada la fase prototipo, el despliegue en la piscina del Instituto de Termalismo de la Univ de Bordeaux será el primer piloto.
Two pilot actions will be developed and will contribute to the output indicator RCO84. The pilot actions are characterised by their cross-border and cooperative nature between the beneficiaries and the associated partners of the project and aim to implement the results of the study and scientific analysis activities of WG1 and WG2. The first pilot action aims to study the transferability of bio-products validated in the previous activities through the industrial incorporation and marketing of stabilised functional ingredients developed from agroforestry residual biomass. A value chain will be developed between the partners INGREDALIA, TAGUS Valey and ARGAL that will be based on the results of the GT1 and that will result in the testing and possible commercialisation of new sausages with biofunctional ingredients. The second pilot action seeks to replicate a transnational biorefinery process in the agroforestry sector that can be transferred to other entities in the cooperation space. The value chain will consist of the associated partners Alliance Forêts-Bois, Sogibois, FBS, TMAD and ENCE, who will provide the raw materials and partners INPT, INRAE, UVIGO, UMINHO, CETIM and BLC3 Evolution, who will take on the transformation and conversion. The efficiency and feasibility of this process will be analysed in order to study its possible continuity and replicability after the completion of the project. The achievements and results of these actions will in turn feed transnational strategies and provide consortium partners with very useful practical experience to ensure the transfer of validated by-products and processes.
